Furthermore, pathway analysis suggested enrichment of estrogen and apelin signaling pathways in PoPH as compared to the non-PoPH cirrhosis liver, and biomarker analyses confirmed low levels of circulating BMP9 distinguished PoPH from non-PoPH cirrhosis and IPAH. This evidence concerns the gene GDF2 and Pulmonary arterial hypertension associated with portal hypertension.